Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1)

Pharmacogenetics

Volumn 14, Issue 7, 2004, Pages 397-406

  Husain, Anwar ^a   Barker, David F ^a   States, J Christopher ^a   Doll, Mark A ^a   Hein, David W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Breast neoplasms; Human arylamine N acetyltransferase 1; Non coding exons; Promoter; RLM RACE

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; COMPLEMENTARY DNA; LUCIFERASE; MESSENGER RNA;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DATA BASE; DNA TRANSCRIPTION; EXON; GENE IDENTIFICATION; GENE STRUCTURE; GENE VECTOR; GENETIC CODE; GENOMIC FRAGMENT; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; EXONS; FEMALE; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; TRANSFECTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 3242787887     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000114755.08559.6e     Document Type: Article

References (48)

1. Felton JS, Knize MG, Salmon CP, Malfatti MA, Kulp KS. Human exposure to heterocyclic amine food mutagens/carcinogens: relevance to breast cancer. Environ Mol Mutagen 2002; 39:112-118.
2. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, et al. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993; 14:1633-1638.
3. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 1995; 16:39-52.
4. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhlP). Carcinogenesis 1991; 12:1503-1506.
5. Ito N, Hasegawa R, Imaida K, Tamano S, Hagiwara A, Hirose M, et al. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in the rat. Mutat Res 1997; 376:107-114.
6. Hein DW. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett 2000; 112-113:349-356.
7. Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, Sellers TA, et al. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8:233-239.
8. Krajinovic M, Ghadirian P, Richer C, Sinnett H, Gandini S, Perret C, et al. Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 2001; 92:220-225.
9. Hein DW, Wen W, Doll MA, Gross MD, Deitz AC, Anderson KE, et al. N-acetyltransferase (NAT1 & NAT2) genetic polymorphisms modify breast cancer risk from cigarette smoking and well-done meat consumption. Cancer Epidemiol Biomarkers Prev 2003; 12:1293S.
10. Millikan RC, Pittman GS, Newman B, Tse CK, Selmin O, Rockhill B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7:371-378.
11. Millikan RC. NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9:217-219.
12. Windmill KF, Gaedigk A, Hall PM, Samaratunga H, Grant DM, McManus ME. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci 2000; 54:19-29.
13. Ward A, Hickman D, Gordon JW, Sim E. Arylamine N-acetyltransferase in human red blood cells. Biochem Pharmacol 1992; 44:1099-1104.
14. Smelt VA, Upton A, Adjaye J, Payton MA, Boukouvala S, Johnson N, et al. Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet 2000; 9:1101-1107.
15. Rodrigues-Lima F, Cooper RN, Goudeau B, Atmane N, Chamagne AM, Butler-Browne G, et al. Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase. J Histochem Cytochem 2003; 51:789-796.
16. Meisel P, Giebel J, Peters M, Foerster K, Cascorbi I, Wulff K, et al. Expression of N-acetyltransferases in periodontal granulation tissue. J Dent Res 2002; 81:349-353.
17. Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 1998; 34:914-920.
18. Hickman D, Pope J, Patil SD, Fakis G, Smelt V, Stanley LA, et al. Expression of arylamine N-acetyltransferase in human intestine. Gut 1998; 42:402-409.
19. Cribb AE, Grant DM, Miller MA, Spielberg SP. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes. J Pharmacol Exp Ther 1991; 259:1241-1246.
20. Adam PJ, Berry J, Loader JA, Tyson KL, Craggs G, Smith P, et al. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to Etoposide in vitro. Mol Cancer Res 2003; 1:826-835.
21. Minchin RF. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 1995; 307:1-3.
22. Ward A, Summers MJ, Sim E. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 1995; 49:1759-1767.
23. Sadrieh N, Davis CD, Snyderwine EG. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res 1996; 56:2683-2687.
24. Matas N, Thygesen P, Stacey M, Risch A, Sim E. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet Cell Genet 1997; 77:290-295.
25. Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51:1409-1416.
26. Brooks SC, Locke ER, Soule HD. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 1973; 248:6251-6253.
27. Tatusova TA, Madden TL. BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett 1999; 174:247-250.
28. Schuler GD. Pieces of the puzzle: expressed sequence tags and the catalog of human genes. J Mol Med 1997; 75:694-698.
29. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12:996-1006.
30. Suzuki Y, Yamashita R, Nakai K, Sugano S. DBTSS: DataBase of human transcriptional start sites and full-length cDNAs. Nucleic Acids Res 2002; 30:328-331.
31. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-410.
32. Kent WJ. BLAT - the BLAST-like alignment tool. Genome Res 2002; 12:656-664.
33. Mitchell KR, Warshawsky D. Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes. Toxicol Lett 2003; 139:11-23.
34. Butcher NJ, Arulpragasam A, Pope C, Minchin RF. Identification of a minimal promoter sequence for the human N-acetyltransferase type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1). Biochem J 2003; 376:441-448.
35. Harrington JJ, Sherf B, Rundlett S, Jackson PD, Perry R, Cain S, et al. Creation of genome-wide protein expression libraries using random activation of gene expression. Nature Biotechnol 2001; 19:440-445.
36. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000; 9:29-42.
37. Ohsako S, Deguchi T. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 1990; 265:4630-4634.
38. Smale ST. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim Biophys Acta 1997; 1351:73-88.
39. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 1990; 212:563-578.
40. Javahery R, Khachi A, Lo K, Zenzie-Gregory B, Smale ST. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol 1994; 14:116-127.
41. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26:362-367.
42. Ohsako S, Ohtomi M, Sakamoto Y, Uyemura K, Deguchi T. Arylamine N-acetyltransferase from chicken liver II. Cloning of cDNA and expression in Chinese hamster ovary cells. J Biol Chem 1988; 263:7534-7538.
43. Zhang T, Haws P, Wu Q. Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res 2004; 14:79-89.
44. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 2003; 86:219-224.
45. Deguchi T. Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem 1992; 267:18140-18147.
46. Han B, Dong Z, Liu Y, Chen Q, Hashimoto K, Zhang JT. Regulation of constitutive expression of mouse PTEN by the 5′-untranslated region. Oncogene 2003; 22:5325-5337.
47. Keene RG, Mueller A, Landick R, London L. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes. Nucleic Acids Res 1999; 27:3173-3182.
48. Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome Biol 2002; 3:0004.1-0004.10.